Small cell carcinomas comprise approximately 20% of all primary pulmonary malignant tumours (Greco & Oldham, 1979) . They form part of the amine precursor uptake and decarboxylation (APUD) system with respect to their cytochemical properties and it is well established that cells of the APUD series frequently produce monoamine neurotransmitters and hormones (Le Douarin, 1982; Pearse, 1969) . It is therefore not surprising that small cell carcinomas are often associated with the ectopic production of hormones, resulting in paraneoplastic syndromes, such as Cushing's disease (Richardson et al., 1978) . At present, it is unknown whether the tumour hormone production is a simple reflection of derepression of genetic material consequent to dedifferentiation or whether the hormones exert a positive influence on the growth of the tumour cells through an autocrine mechanism (Sporn & Todaro, 1980) . The latter possibility would require the presence of hormone receptors on tumour cell membranes. Recently, it has become possible to establish clonable cell lines derived from human small cell carcinomas of the lung (Gazdar et al., 1980) . Subsequently, it has been shown that these cell lines invariably produce high levels of material immunoreactive with antibodies raised against the amphibian peptide bombesin (Moody et al., 1981) and a recent study has indicated that the immunoreactive material probably corresponds to the mammalian peptide gastrin-releasing peptide (Yamaguchi, 1983) .
Neurotensin is a thirteen amino acid peptide isolated from mammalian brain and small intestine (Carraway & Leeman, 1973; Leeman & Carraway, 1982 neurotensin (Araki et al., 1973) . Whereas no xenopsin-like immunoreactivity is present in mammalian tissues (Goedert et al., in press) neurotensin-like immunoreactivity is found throughout the central nervous system of mammals (Emson et al. 1982) . In peripheral tissues, it is present in high concentrations in the anterior pituitary gland and the gastrointestinal mucosa and in low concentrations in most other tissues, including the lung (Goedert et (Nemeroff et al., 1983) . (Lowry et al., 1951) , using bovine serum albumin as the standard.
Immunohistochemistry
Cells were centrifuged at 600 rpm onto poly-Llysine coated slides and fixed in parabenzoquinone. They were stained by using a modification of the indirect immunofluorescence technique (Gu et al., 1983) . Briefly, they were incubated at 4°C for 24h with a rabbit antiserum raised against neurotensin (diluted 1: 500) (Goedert et al., 1983 
Results
High levels of NTLI were present in extracts of all the small-cell carcinoma cell lines investigated (Table I ). The immunoreactive material was characterised further by gel filtration on a Sephadex G-25 column (Figure la) and on reversephase HPLC (Figure lb) . With both systems, the immunoreactivity emerged as a single peak in the same position as synthetic neurotensin, and could be detected in equivalent amounts using both carboxyand amino-terminal directed radioimmunoassays. The amphibian peptide xenopsin could not be detected in any of the small cell carcinoma lines (Table I) . Neurotensin-positive cells were visualised using an antiserum directed against the carboxy-terminal end of the molecule by indirect immunofluorescence. Numerous neurotensin-positive cells were present and the -13) ) and 22NaCl (total volume, Vt). (b) The immunoreactive peak was subjected to high performance liquid chromatography on reverse phase using a linear 5-35% acetonitrile gradient. Fractions were assayed using antisera directed against the neurotensin aminoterminus (0) and carboxy-terminus (A). ( Yamaguchi et al., 1983) , it is the mammalian peptide neurotensin and not the structurally related amphibian peptide xenopsin that is present in the small cell lung carcinoma lines. No evidence was obtained for the presence of neurotensin receptors in the small cell carcinoma lines, which would not support a paracrine mode of action for neurotensin in these cell lines. The possible function of NTLI in human small cell carcinomas is unknown at present. It is conceivable that the immunoreactive material is released into the general circulation where it may be implicated in the pathogenesis of paraneoplastic syndromes. Previously, NTLI has been shown to be present in endocrine pancreatic tumours (Blackburn et al., 1980; Feurle et al., 1981; Gutniak et al., 1980; Theodorsson-Norheim et al., 1983) and it also was found in human small cell lung carcinomas (Wood et al., 1981 (Wood et al., , 1983 . At present, the only cell lines known to produce NTLI have been derived from a rat medullary carcinoma of the thyroid and a rat phaeochromocytoma (Tischler et al., 1982; Zeytinoglu et al., 1980) . Our findings constitute the first example of cell lines of human origin producing NTLI. It should now be possible to study the factors involved in the biosynthesis of human neurotensin and the small cell lung carcinoma lines may constitute a favourable material for elucidating the structure of the human neurotensin gene.
